Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Noninvasive neuromodulation reduces symptoms of restless legs syndrome.
Buchfuhrer MJ, Baker FC, Singh H, Kolotovska V, Adlou B, Anand H, de Zambotti M, Ismail M, Raghunathan S, Charlesworth JD. Buchfuhrer MJ, et al. J Clin Sleep Med. 2021 Aug 1;17(8):1685-1694. doi: 10.5664/jcsm.9404. J Clin Sleep Med. 2021. PMID: 33949942 Free PMC article. Clinical Trial.
Sensory stimuli and the restless legs syndrome.
Burbank F, Buchfuhrer MJ. Burbank F, et al. Among authors: buchfuhrer mj. J Clin Sleep Med. 2014 Dec 15;10(12):1363. doi: 10.5664/jcsm.4306. J Clin Sleep Med. 2014. PMID: 25348247 Free PMC article. No abstract available.
Treatment response to sleep, pain, and mood disturbance and their correlation with sleep disturbance in adult patients with moderate-to-severe primary restless legs syndrome: Pooled analyses from 3 trials of gabapentin enacarbil.
Bogan RK, Lee DO, Buchfuhrer MJ, Jaros MJ, Kim R, Shang G. Bogan RK, et al. Among authors: buchfuhrer mj. Ann Med. 2015 May;47(3):269-77. doi: 10.3109/07853890.2015.1025825. Epub 2015 Apr 15. Ann Med. 2015. PMID: 25874578 Clinical Trial.
Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D, Silber MH, Winkelman JW, Högl B, Bainbridge J, Buchfuhrer M, Hadjigeorgiou G, Inoue Y, Manconi M, Oertel W, Ondo W, Winkelmann J, Allen RP. Garcia-Borreguero D, et al. Sleep Med. 2016 May;21:1-11. doi: 10.1016/j.sleep.2016.01.017. Epub 2016 Feb 23. Sleep Med. 2016. PMID: 27448465 Free article.
The Appropriate Use of Opioids in the Treatment of Refractory Restless Legs Syndrome.
Silber MH, Becker PM, Buchfuhrer MJ, Earley CJ, Ondo WG, Walters AS, Winkelman JW; Scientific and Medical Advisory Board, Restless Legs Syndrome Foundation. Silber MH, et al. Among authors: buchfuhrer mj. Mayo Clin Proc. 2018 Jan;93(1):59-67. doi: 10.1016/j.mayocp.2017.11.007. Mayo Clin Proc. 2018. PMID: 29304922
Validation of the self-administered version of the international Restless Legs Syndrome study group severity rating scale - The sIRLS.
Sharon D, Allen RP, Martinez-Martin P, Walters AS, Ferini Strambi L, Högl B, Trotti LM, Buchfuhrer M, Swieca J, Bogan RK, Zak R, Hensley JG, Schaefer LA, Marelli S, Zucconi M, Stefani A, Holzknecht E, Olvera V, Meaklim H, Laska I, Becker PM; International RLS Study Group. Sharon D, et al. Sleep Med. 2019 Feb;54:94-100. doi: 10.1016/j.sleep.2018.10.014. Epub 2018 Oct 29. Sleep Med. 2019. PMID: 30529783
19 results